Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term stability and performance of Cas9/guide RNA-based gene drives in anopheline mosquitoes.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

<i>Chlorella sorokiniana</i> KU.B2 microalga inhibits <i>Aedes aegypti</i> larval development.

Current research in insect science·2026
Same author

Effects of Chlorella sorokiniana KU.B2 microalga on the development of Culex quinquefasciatus (Diptera: Culicidae) larvae.

Journal of medical entomology·2026
Same author

Real-World Data on the Use of Intravenous Fosfomycin for the Treatment of Central Nervous System Infections: a Subgroup Analysis from the FORTRESS Study.

Infectious diseases and therapy·2026
Same author

ERS statement: Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults.

The European respiratory journal·2026
Same author

Impact of appropriate antimicrobial therapy on patient outcomes and antimicrobial use: a sub analysis of the DIANA Study Dataset.

Intensive care medicine·2026

Related Experiment Video

Updated: Jul 25, 2026

Building a Better Mosquito: Identifying the Genes Enabling Malaria and Dengue Fever Resistance in A. gambiae and A. aegypti Mosquitoes
15:03

Building a Better Mosquito: Identifying the Genes Enabling Malaria and Dengue Fever Resistance in A. gambiae and A. aegypti Mosquitoes

Published on: July 4, 2007

11.0K

Curing mosquitoes with genetic approaches for malaria control.

Mary Kefi1, Victor Cardoso-Jaime1, Sally A Saab1

  • 1Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Trends in Parasitology
|May 17, 2024
PubMed
Summary

Genetically modified mosquitoes that cannot transmit malaria offer a promising new tool for disease elimination. This approach involves spreading engineered genes through mosquito populations to block malaria transmission.

Keywords:
AnophelesPlasmodiummalaria vectorspopulation modificationtransgenesis

More Related Videos

Small-Cage Laboratory Trials of Genetically-Engineered Anopheline Mosquitoes
07:45

Small-Cage Laboratory Trials of Genetically-Engineered Anopheline Mosquitoes

Published on: May 1, 2021

2.7K
Microinjection Method for Anopheles gambiae Embryos
05:39

Microinjection Method for Anopheles gambiae Embryos

Published on: July 7, 2021

4.6K

Related Experiment Videos

Last Updated: Jul 25, 2026

Building a Better Mosquito: Identifying the Genes Enabling Malaria and Dengue Fever Resistance in A. gambiae and A. aegypti Mosquitoes
15:03

Building a Better Mosquito: Identifying the Genes Enabling Malaria and Dengue Fever Resistance in A. gambiae and A. aegypti Mosquitoes

Published on: July 4, 2007

11.0K
Small-Cage Laboratory Trials of Genetically-Engineered Anopheline Mosquitoes
07:45

Small-Cage Laboratory Trials of Genetically-Engineered Anopheline Mosquitoes

Published on: May 1, 2021

2.7K
Microinjection Method for Anopheles gambiae Embryos
05:39

Microinjection Method for Anopheles gambiae Embryos

Published on: July 7, 2021

4.6K

Area of Science:

  • Vector biology
  • Genetic engineering
  • Public health

Background:

  • Malaria remains a significant global health issue due to limitations in current prevention strategies.
  • Transgenic mosquitoes offer a novel approach to malaria control by disrupting parasite transmission.

Purpose of the Study:

  • To review recent advancements in developing genetically modified mosquitoes for malaria control.
  • To highlight the progress and challenges in making Anopheles mosquitoes unable to transmit the malaria parasite.

Main Methods:

  • Review of scientific literature on transgenic mosquito technology.
  • Analysis of genetic engineering tools and strategies for vector modification.
  • Examination of progress towards field deployment and regulatory considerations.

Main Results:

  • Significant progress in identifying targets and optimizing genetic tools for malaria vector control.
  • Advancements in gene drive technologies for efficient spread in mosquito populations.
  • Successful laboratory and early-stage field trials demonstrating proof-of-concept.

Conclusions:

  • Transgenic mosquito technology, combined with existing methods, shows great potential for malaria elimination.
  • Ongoing challenges include optimizing gene spread, ensuring ecological safety, and navigating regulatory pathways.
  • Continued research and development are crucial for the successful implementation of genetically modified mosquitoes in malaria-endemic regions.